Beijing, China

Wen Xin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in RNA Research by Inventor Wen Xin

Introduction

Wen Xin is a notable inventor based in Beijing, China. He has made significant contributions to the field of transcriptomics and RNA sequencing. His innovative approach to RNA sample processing has the potential to enhance research outcomes in various scientific domains.

Latest Patents

Wen Xin holds a patent for a method titled "Method for removing non-target RNA from RNA sample." This patent describes a process that involves performing reverse transcription on an RNA sample using a reverse transcription primer. The method effectively removes non-target RNA, allowing for the isolation of target first-strand cDNA. The process includes hybridizing non-target first-strand cDNA with a specific probe and digesting the resulting complex with a duplex-specific nuclease. This innovation is characterized by its simplicity, flexibility, and cost-effectiveness, making it a valuable tool for researchers in the field.

Career Highlights

Wen Xin is associated with Beijing Transgen Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in improving RNA sequencing techniques.

Collaborations

Wen Xin collaborates with Liang Geng, a talented researcher in the same field. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.

Conclusion

Wen Xin's contributions to RNA research through his patented methods highlight the importance of innovation in advancing scientific knowledge. His work not only simplifies RNA processing but also significantly impacts the field of transcriptomics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…